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a  b  s  t  r  a  c  t
BACKGROUND:  Paragangliomas  are  rare  neoplasms  that originate  from  the  neural  crest.  They  are  malig-
nant  in  approximately  10%  of  cases,  with  a 50%  survival  rate at 5  years  from diagnosis.  In  most  cases,
manifestations  of malignancy  (such  as  metastasis)  are  lacking,  and  paragangliomas  are considered  benign
lesions.  Pancreatic  paragangliomas  are  extremely  rare, with  only  31 cases  described  in the  scientiﬁc
literature  to date.
CASE SUMMARY:  Here  we describe  a case  of a 55-year-old  Caucasian  male  patient  referred  to our  insti-
tution  in September  2013  for lumbar  pain  lasting  ﬁve  months.  The  ultrasound  and  the  CT scan  revealed
a  2.5  cm solid  nodule  located  in  the uncinate  process  of the  pancreas.  On  the  basis  of  this  evidence,
the  preoperative  diagnosis  was  a pancreatic  neuroendocrine  tumor  (NET),  which  was  further  conﬁrmed
by a  subsequent  In-Pentetreotide  Scan  examination.  A  pylorus-preserving  duodenocephalopancreasec-
tomy was  performed.  Pancreatic  paraganglioma  was  the  ﬁnal  pathological  diagnosis.  Rare  localizations
of  paraganglioma  are  often  discovered  casually,  during  imaging  examinations  for  other  clinical  reasons,
as happened  in  the  case  of  our patient.  It  appears  evident  that  the  preoperative  diagnosis  of pancreatic
paragangliomas  is extremely  challenging.  Surgery  represents  the cornerstone  of the  clinical  manage-
ment  of  these  neoplasms,  primarily  for the  need  of a deﬁnitive  diagnosis,  which  is difﬁcult  to assess
preoperatively  in  most  cases.
CONCLUSIONS:  Our strategy  is the same  as  that  adopted  for  the  management  of  pancreatic  NETs;  the
dimensional  limit  for a conservative  resection  is 2 cm,  while  major  resections  (Whipple’s  approach  or
distal  pancreatectomy)  should  be  employed  in  larger  tumors,  which  are  generally  associated  with a
worse prognosis.
©  2016  The  Authors.  Published  by  Elsevier  Ltd  on  behalf  of  IJS Publishing  Group  Ltd.  This is  an  open
he  CCaccess  article  under  t
. Introduction
Paragangliomas are rare neoplasms that originate from the neu-
al crest and involve both the sympathetic and parasympathetic
anglia [1]. They are malignant in approximately 10% of cases,
ith a 50% survival rate at 5 years from diagnosis. In most cases,
anifestations of malignancy (such as metastasis) are lacking, and
aragangliomas are considered benign lesions. Pancreatic paragan-
liomas are extremely rare, with only 31 cases described in the
cientiﬁc literature to date.
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2. Case report
A 55-year-old Caucasian male patient was referred to our
institution in September 2013 for lumbar pain lasting ﬁve
months. Inﬂammatory, degenerative and rheumatic alterations
were excluded by clinical examination, while the clinical examina-
tion of the abdomen did not evidence any manifestation of disease.
The subsequent ultrasonographic (US) examination revealed a
2.5 cm solid nodule, located in the uncinate process of the pan-
creas. The lesion was further studied by contrast enhancement
ultrasound (CEUS) and computed tomography (CT) scan (Fig. 1A
and B). Arterial phase hypervascularity and slow wash-out were
observed (Fig. 1C and D), leading to the hypothesis of a neuroen-
docrine pancreatic tumor (NET), which was further conﬁrmed by
a subsequent In-Pentetreotide Scan examination. The patient had
no personal or family history of neoplastic diseases. All the bio-
chemical tests returned results within normal ranges, including
roup Ltd. This is an open access article under the CC BY-NC-ND license (http://
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codule  located in the uncinate process of the pancreas.
hromogranin, blood catecholamines, and urinary metanephrines,
s well as serum tumor markers (Ca19-9, CEA, Ca15-3). On the
asis of this evidence, the preoperative diagnosis was a pancreatic
ET. A pylorus-preserving duodenocephalopancreasectomy was
erformed in September 2013.
On gross pathological examination the pancreatic lesion mea-
ured 1.3 cm,  was brownish in color, solid consistency, and
ell-circumscribed. Microscopically, the lesion was organized in
ests of variable dimensions, with numerous blood vessels and
emorrhagic areas (Fig. 2a). The neoplastic cells showed high
ariability in size and shape. The nuclei were pleomorphic, some-
imes very large, and the cytoplasms abundant, ﬁnely granular and
osinophilic (Fig. 2b). Strong immunohistochemical positivity for
hromogranin A and synaptophysin was observed (Fig. 2c), as wellas focal positivity for S100 and somatostatin, while cytokeratins
(CAM 5.2) (Fig. 2d) and AE1/AE3 were negative. The ﬁnal patholog-
ical diagnosis was pancreatic paraganglioma.
The patient was discharged on the 15th postoperative day. He
underwent a CT scan of the lungs at periods of six months, one year
and two years postoperatively, with no evidence of progression
of the lung nodule discovered. He is currently alive and disease
free. Informed consent for the publication of the present report was
obtained; the CARE guidelines were employed for reporting [2].3. Discussion
Paragangliomas are neoplasms originating from the ganglia of
the autonomous nervous system, which usually involve both the
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Fig. 2. A (H&E, 4×) – Hematoxylin and eosin staining showing well circumscribed tumor with numerous blood vessels. B (H&E, 40×) – The tumor cells are arranged in nests

























t“Zellballen”) bound by sostentacular cell and ﬁbrovascular stroma. Nuclear atypia
istochemistry of the “Zellballen” neoplastic cells demonstrates positivity for syna
howed negative staining in neoplastic cells for cytokeratin (CAM5.2) and positive s
ympathetic and parasympathetic ganglia equally [1]. The former,
n their extra-adrenal manifestation, affects mainly the sympa-
hetic chain, while the latter affects generally the head and the neck,
specially the ganglia of the vagus and glossofaringeal nerves. Other
ocalizations, such the one described in our case, are extremely rare
3]. Globally, paragangliomas are rare tumors, with a prevalence of
.8 cases per 100,000 inhabitants, and approximately 500–1600
ew cases per year estimated in the United States.
The gross appearance of paragangliomas is that of a richly
ascularized mass, growing typically near to large blood ves-
els or nerves. Nevertheless, from a histological point of view,
ifferential diagnoses with meningiomas, schwannomas, heman-
iopericytomas, melanomas, and various metastatic carcinomas
ay  be challenging [4]. Fortunately, immunohistochemical positiv-
ty for neurospeciﬁc enholase (NSE), synaptophysin, chromogranin,
nd no staining for cytokeratins, is diagnostic of paragangliomas [5].
he only certain element of malignancy is, usually, the presence
f metastasis [6]. It is evident that the diagnosis of a paragan-
lioma is often obtained thanks to its clinical manifestations, such
s the anatomical localization of the lesion and the presence of
yperadrenalism; clinical diagnosis is difﬁcult in cases of a rare
ocalization, like the case we describe herein, which involve the
ancreatic or peripancreatic chromafﬁn cells.
Paragangliomas of the pancreas are often discovered inciden-
ally, during imaging examinations for other clinical reasons, asmon and is not an expression of malignancy. C (synaptophysin, 10×)  – Immuno-
ysin; the normal pancreas is negative. D (CAM 5.2, 20×) – Immunohistochemistry
g in non-neoplastic pancreatic cells.
happened in our case. When symptomatic, the clinical manifesta-
tions of paragangliomas are due to the compression of neighboring
anatomical structures; abdominal pain, dyspepsia, weight loss, and
asthenia are the commonest ones. Only 31 similar cases have been
described in the scientiﬁc literature, this makes the real pancreatic
lesions rarer, and the scientiﬁc data on their management poorer.
The natural history of the disease appears relatively benign. Only in
a few cases have loco-regional lymph node involvement or distant
metastasis been reported; the liver and the right adrenal gland were
the organs affected by distant metastasis in the cases described in
literature. Furthermore, no correlations between the dimensions of
the lesions and their clinical course were evidenced. Surgery rep-
resents the cornerstone of the clinical management of pancreatic
paragangliomas, primarily for the need of a deﬁnitive diagnosis,
which is difﬁcult to assess preoperatively in most cases.
In conclusion, the rarity of these neoplasms makes their clinical
management and follow-up really challenging. The choice between
a conservative approach, which leads to diagnosis but may  require
re-intervention to achieve the oncological clearance, or an a pri-
ori radical approach, is still a matter of debate. Our strategy is
the same as that adopted for the management of pancreatic NETs,
described in recent consensus guidelines; the dimensional limit for
a conservative resection is 2 cm,  while major resections (Whipple’s
approach or distal pancreatectomy) should be employed in larger
tumors, which are generally associated with a worse prognosis.
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